Kaye Jack 4

What Happened

• Kaye Jack, a director of uniQure N.V. (QURE), exercised 2,645 stock options at an exercise price of $16.04 per share on 2026-06-03 (total cost $42,426) and sold the same 2,645 shares in an open-market transaction at $30.01 per share (gross proceeds $79,376). The filing also records a technical derivative conversion entry at $0.00 associated with the option exercise.
• The combined transactions resulted in gross proceeds of $79,376 and an approximate spread/proceeds over exercise cost of $36,950 before fees and taxes. The sale was executed under a pre-established Rule 10b5-1 trading plan.

Key Details

• Transaction date: June 3, 2026; Form 4 filed June 5, 2026 (within the typical two-business-day reporting window).
• Exercise: 2,645 shares @ $16.04 = $42,426 (code M — option exercise/conversion).
• Sale: 2,645 shares @ $30.01 = $79,376 (code S — open market sale).
• Derivative conversion entry: 2,645 shares @ $0.00 (technical reporting of conversion).
• Footnotes: Transactions effected pursuant to a 10b5-1 sales plan adopted June 16, 2025 (F1). The option vested in full on February 24, 2023 (F2).
• Shares owned after the transaction: not specified in the provided filing excerpt.

Context

• This sequence is a common "exercise-and-sell" (cashless) pattern: the insider exercised vested options and sold the resulting shares the same day under a Rule 10b5-1 plan, which is typically used to avoid trading-window timing issues.
• Sales by directors under 10b5-1 plans are often routine and are not, by themselves, proof of a change in the insider’s view of the company.